CIP2A is overexpressed in various tumor types,24 and we demonstrated that it is also highly expressed in melanoma and is closely associated with metastasis and poor prognosis, highlighting the possibility of developing anticancer drugs by targeting CIP2A. The gene discussed is CIP2A; the disease is melanoma.